Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7221 results

Mundipharma launches monoclonal antibody Remsima in six European markets

26-02-2015

Privately-held Swiss drugmaker Mundipharma Laboratories is launching Remsima (infliximab) this month…

Anti-Arthritics/RheumaticsEuropeMarkets & MarketingMundipharmaPharmaceuticalRemsima

Significant drop in pharma applications to EPO shows pace of innovation is dropping

Significant drop in pharma applications to EPO shows pace of innovation is dropping

26-02-2015

The European Patent Office (EPO) has reported an increase in the number of patent filings for the fifth…

BiotechnologyEPOEuropeLegalPharmaceutical

Economist Pharma Summit: BRIC countries must be at forefront of AMR fight, says Jim O'Neill

Economist Pharma Summit: BRIC countries must be at forefront of AMR fight, says Jim O'Neill

26-02-2015

Jim O'Neill, chair of the UK government's review on antimicrobial resistance (AMR), spoke of the need…

AMRAntibiotics and Infectious diseasesPharma SummitPharmaceuticalUK

Ablynx 2014 financial results sees loss decrease thanks to collaborations

Ablynx 2014 financial results sees loss decrease thanks to collaborations

26-02-2015

Belgian drug developer Ablynx has released its 2014 full year results, reporting a decreased loss from…

AblynxBelgiumFinancialMerck & CoPharmaceutical

‘New option’ for diabetes as Sanofi receives FDA approval of Toujeo

‘New option’ for diabetes as Sanofi receives FDA approval of Toujeo

26-02-2015

The US Food and Drug Administration has approved French pharma major Sanofi’s Toujeo (insulin glargine…

DiabetesPharmaceuticalRegulationSanofiToujeoUSA

US FDA approves new antibacterial drug Avycaz

US FDA approves new antibacterial drug Avycaz

26-02-2015

The US Food and Drug Administration has approved antibacterial drug Avycaz (ceftazidime-avibactam) to…

ActavisAntibiotics and Infectious diseasesceftazidime-avibactamForest PharmaceuticalsPharmaceuticalRegulationUSA

Atrial fibrillation market to double by 2020 before steep decline

Atrial fibrillation market to double by 2020 before steep decline

26-02-2015

The global market for atrial fibrillation treatment will more than double in value between 2013 and 2020,…

Cardio-vascularChemistryMarkets & MarketingMedicineOrganic chemistryPharmaceuticalStroke

Sri Lanka must look globally and build exports, report says

Sri Lanka must look globally and build exports, report says

26-02-2015

Sri Lankan pharma companies must aim to penetrate the global market since the internal market is insufficient,…

Bharat BookMarkets & MarketingPharmaceuticalPolitical geographySri Lanka

Sanofi's golden handshake for new chief Olivier Brandicourt under fire

Sanofi's golden handshake for new chief Olivier Brandicourt under fire

25-02-2015

The proposed bonus for Olivier Brandicourt, the new chief executive of Sanofi has drawn criticism from…

Business FinanceFinancialFrancePharmaceuticalPoliticsSanofi

NICE recommends Sovaldi and Olysio for hepatitis C

NICE recommends Sovaldi and Olysio for hepatitis C

25-02-2015

The UK’s National Institute for Health and Care Excellence (NICE) has published final guidance recommending…

Anti-viralsGilead SciencesJanssenOlysioPharmaceuticalRegulationSovaldiUK

Takeda acquires 13 products from Turkish company Neutec

Takeda acquires 13 products from Turkish company Neutec

25-02-2015

Takeda GmbH, the wholly-owned subsidiary of Japanese drugmaker Takeda has signed an agreement to obtain…

Markets & MarketingMergers & AcquisitionsPharmaceuticalTakeda PharmaceuticalTurkey

Fujifilm's favipiravir performs well in early-stage Ebola study

Fujifilm's favipiravir performs well in early-stage Ebola study

25-02-2015

A study conducted in Guinea has shown that Fujifilm’s favipiravir halves mortality rates in patients…

Antibiotics and Infectious diseasesfavipiravirFujifilmGuineaPharmaceuticalResearch

Takeda consolidates business in Singapore, opening new office

Takeda consolidates business in Singapore, opening new office

25-02-2015

Japanese drug major Takeda has opened its new office in Biopolis, Singapore. The space will host its…

PharmaceuticalProductionResearchSingaporeTakeda PharmaceuticalsVaccines

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

25-02-2015

The UK’s National Institute for Health and Care Excellence has recommended Inlyta (axitinib), marketed…

DendreonInlytaOncologyPfizerPharmaceuticalPricingProvengeRegulationUKValeant Pharmaceuticals International

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

24-02-2015

US pharma giant Pfizer has announced positive top-line results of a Phase II study of Trumenba (meningococcal…

Antibiotics and Infectious diseasesPfizerPharmaceuticalResearchTrumenbaUSA

Considerable commercial interest in Alzheimer's pipeline despite high rate of attrition, report says

Considerable commercial interest in Alzheimer's pipeline despite high rate of attrition, report says

24-02-2015

Despite a high rate of attrition, there is a considerable level of commercial interest in the Alzheimer’s…

AlzheimerGBI ResearchNeurologicalPharmaceuticalResearch

30% increase in R&D projects for neglected diseases in 2014; report

24-02-2015

Trade group the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has released…

GlobalPharmaceuticalResearchTropical diseases

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

24-02-2015

The US Federal Trade Commission has put conditions on the proposed acquisition by Novartis of GlaxoSmithKline’s…

Array BioPharmaGSKLegalMergers & AcquisitionsNovartisOncologyPharmaceuticalRegulationResearchUSA

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

Ferring acquires novel drug delivery technology from CTCBIO

24-02-2015

Privately-held Switzerland-headquartered Ferring Pharmaceuticals has signed an agreement with CTCBIO…

CTCBIOFerring PharmaceuticalsLicensingPharmaceutical

Aquavit to invest in biopharma R&D and manufacturing in South Korea

24-02-2015

Aquavit Life Sciences, the South Korea-based subsidiary of privately-held US firm Aquavit Pharmaceuticals,…

AquavitPharmaceuticalProductionResearchSouth Korea

Merck and Medicines Patent Pool sign licensing agreement for pediatric raltegravir

Merck and Medicines Patent Pool sign licensing agreement for pediatric raltegravir

24-02-2015

The Medicines Patent Pool has announced a license with US pharma giant Merck & Co for pediatric formulations…

Anti-viralsMerck & CoPharmaceuticalProductionRaltegravir Tablets

US FDA approves Novartis’ Farydak, the first HDAC inhibitor for MM patients

24-02-2015

The US Food and Drug Administration yesterday approved Swiss pharma giant Novartis’ Farydak (panobinostat,…

FarydakNovartisOncologypanobinostatPharmaceuticalRegulationUSA

1 to 25 of 7221 results

COMPANY SPOTLIGHT

Menarini

Back to top